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El deterioro cognitivo es común en los pacientes alcohólicos. Éste se 
manifiesta por alteraciones en la memoria anterógrada y retrógrada, 
el procesamiento visual-espacial, y en las habilidades cognitivas y la 
atención, siendo algunas reversibles. Las terapias de rehabilitación 
cognitiva podrían mejorar el rendimiento de los pacientes, siendo 
una alternativa terapéutica de interés.  El objetivo de este estudio 
piloto fue evaluar la implementación, viabilidad y efectividad de la 
terapia de rehabilitación cognitiva en pacientes con dependencia al 
alcohol y deterioro cognitivo asociado. Se trata de un estudio piloto 
con 16 pacientes (63% hombres, edad media de 59 años) seguidos 
en la Unidad de Conductas Adictivas de un hospital de tercer nivel. 
Siendo la abstinencia un requisito para la inclusión, durante 6 meses 
una enfermera realizó sesiones semanales de una hora (24 sesiones), 
realizándose ejercicios de psico-estimulación para la mejora del 
rendimiento cognitivo, funcional y social. Se evaluó a los pacientes 
al inicio, al final y pasados 6 meses, mediante las escalas MMSE (test 
Mini-mental de Lobo) y T@M (test de Alteración de Memoria). Sus 
puntuaciones medias respectivas fueron 26.4 (DE 3,16), 29 (DE 1,67) 
y 27 (DE 3,1) para MMSE y 38,7 (DE 6,81), 45,7 (DE 5,6) y 41,1 (DE 
7,86) para T@M. Los datos se analizaron mediante la prueba de 
Friedman y se comparon los distintos periodos temporales mediante 
la prueba de rangos con signo de Wilcoxon, siendo la mayoría de 
comparaciones significativas (p < 0,05). La asistencia y la satisfacción 
fueron elevadas. Así pues, la terapia fue viable, ampliamente aceptada 
y mostró ser efectiva.
Palabras clave:: Dependencia de alcohol; Deterioro cognitivo; 
Rehabilitación cognitiva; Daño cerebral asociado al alcohol.
Many alcohol-dependent patients suffer from cognitive impairment 
of variable severity, manifested by alterations in retrograde and 
anterograde memory, visuospatial processing, cognitive abilities and 
attention, some of which are reversible. In this context, cognitive 
remediation therapies could significantly improve patients’ 
performance; therefore, these are considered a valuable alternative. 
The aim of this study was to implement cognitive remediation therapy 
in patients with alcohol dependence and cognitive impairment and 
evaluate its viability and effectiveness. The participants were sixteen 
abstinent, alcohol-dependent patients (mean age of 59 years, 63% 
males) from the Addictive Behaviours Unit of a tertiary hospital. Over 
6 months, a nurse led 1-hour weekly sessions (24 sessions in total) 
during which exercises for improving functional, social and cognitive 
performance were completed. Patients were assessed at baseline, at 
the end of the study and 6 months later, using the Mini-Mental State 
Examination (MMSE) and the Memory Alteration Test (M@T). Their 
respective scores were 26.4 (SD 3.16), 29 (SD 1.67) and 27 (SD 3.1) for 
the MMSE and 38.7 (SD 6.81), 45.7 (SD 5.6) and 41.1 (SD 7.86) for 
the M@T. Changes were assessed with both Friedman and Wilcoxon 
signed-rank tests, with mostly statistically significant differences (p < 
0.05). Assistance and satisfaction were high. Therefore, the therapy 
was viable, widely accepted and effective. 
Key words: Alcohol dependence; Cognitive impairment; Cognitive 
remediation; Alcohol-related brain damage.
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The DSM-V (American Psychiatric Association, 2013) defines alcohol use disorders as a con-dition related with ongoing consumption of alcohol in excessive amounts or during a long 
period over one’s lifetime; it is also associated with the 
appearance of behavioural and physical symptoms, inclu-
ding tolerance, abstinence, lack of control over use, and 
health, family and social problems (American Psychiatric 
Association, 2013; Schuckit 2009). The European Union, 
a region in which alcohol production and use is strongly 
rooted, has one of the world’s highest per capita use rates 
(approximately 23 million adults/year are alcohol-depen-
dent) (Rosón Hernández, 2008). In Spain, alcohol use has 
remained stable since the eighties, though the proportion 
of female drinkers has increased.
The World Health Organization (WHO) associates the 
disorder with physical and mental deterioration. This en-
tails a significant increase of both mortality and morbidi-
ty (Varela-Rey, Woodhoo, Martinez-Chantar, Mato, & Lu, 
2013), including neurological, cardiovascular, metabolic 
and neoplasic diseases. 
Alcohol use disorder generates a socioeconomic impact, 
particularly low productivity and health-related expenses. 
In turn, the disorder is strongly correlated with sexual risk 
situations, injuries, suicide, homicide and automobile acci-
dents, the costs of which are difficult to evaluate (Miller et 
al., 2008; Surkan, Fielding-Miller, & Melchior, 2012; Vare-
la-Rey et al., 2013).
Alcohol-related brain damage (ARBD) is currently the 
focus of special attention (Soler-González, Balcells-Olive-
ró, & Gual-Solé, 2014). Behavioural alterations, cognitive 
deficits, amnesia and degenerative changes to the cerebe-
llum are worth highlighting. Neuroimaging has related 
excessive alcohol use with the appearance of structural 
(e.g., loss of volume of brain and cerebellum tissue) and 
functional (e.g., dysfunction of the frontal and temporal 
lobes and their connections) changes (Glass et al., 2009; 
Yeh, Gazdzinski, Durazzo, Sjöstrand, & Meyerhoff, 2007). 
These changes have been related to alterations of episo-
dic memory, attention, visuospatial processing, and emo-
tional processing and decision-making (Pedrero-Perez, 
Rojo-Mota, Ruiz-Sanchez de Leon, Llanero-Luque, & Puer-
ta-Garcia, 2011). On this basis, a patient with alcohol use 
disorder may develop a Neuro-cognitive Disorder (NCD) 
characterized by deficits that last longer than the usual du-
ration of acute abstinence, and which are more likely in ol-
der patients (Gongvatana et al., 2014). It is estimated that 
between 50-70% of alcohol-dependent persons have some 
degree of cognitive deterioration (Glass et al., 2009; Miller 
et al., 2008). The DSM-5 uses the categories “Mild (MND) 
and major neurocognitive disorders associated with subs-
tance abuse”.
The more frequent MND entails difficulty in perfor-
ming some daily tasks that require paying attention and 
following instructions. Ongoing use, with the appearance 
of secondary brain damage, associated with lower neuro-
nal plasticity and other age-related changes, could cause 
patients difficulty in learning and implementing new infor-
mation (Pedrero-Perez et al., 2011). These changes are re-
lated to poor compliance with rules and guidelines, lower 
adherence to treatment, early relapses and few skills for 
refusing alcohol (Bates, Buckman, & Nguyen, 2013; Pedre-
ro -Perez et al., 2011). 
Executive functions and memory, given their close re-
lationship with abstinence and the success of treatments 
for alcohol dependency, have been the most widely stu-
died areas in the field of alcohol. Working memory and 
the capacity for inhibiting response (both based on frontal 
circuits) are highly vulnerable to alcohol use (Lawrence, 
Luty, Bogdan, Sahakian, & Clark, 2009). Other skills, such 
as conceptualization, abstraction and problem-solving are 
also frequently affected (Rupp et al., 2006). Despite the 
existing patterns as regards impact, it is absolutely neces-
sary to emphasize the important heterogeneity among pa-
tients, due to the methodological limitations of published 
research, as well as to the numerous determinant factors 
underlying individual cognitive capacities, such as age, 
gender, cultural level or genetic influence (Bates, Bowden, 
& Barry, 2002). 
Decades of research and clinical experience have focu-
sed current treatment for alcohol use on helping patients 
to reduce or stop their alcohol use through medication, be-
havioural therapies, brief interventions and social skills tra-
ining (Huebner & Kantor, 2010). Studies with patients with 
alcohol use disorder and mild NCD show that the latter may 
interfere with treatment efficiency. Nevertheless, lost cog-
nitive functions may be recovered, at least to a great extent 
(Rojo-Mota et al., 2009). To achieve this, continuous absti-
nence is a critical, though probably insufficient, element. 
In this regard, functional and cognitive rehabilitation 
therapy acquires increasing importance. To date, most pro-
grams have focused on improving executive functions, me-
mory, and other cognitive skills (Alfonso, Caracuel, Delga-
do-Pastor, & Verdejo-García, 2011; Bickel, Yi, Landes, Hill, 
& Baxter, 2011; Houben, Wiers, & Jansen, 2011; Levine et 
al., 2011) with the goal of evaluating their effect on both 
cognitive skills per se, as well as with regards to their impact 
on variables associated with alcohol use. Recently, rehabi-
litation models based on changing automatic and implicit 
processes have also been proposed (Wiers, Eberl, Rinck, 
Becker, & Lindenmeyer, 2011). Alternative programs in-
clude the use of heart rate variability biofeedback (Bates 
& Buckam, 2013), aerobic physical training (Brown et al., 
2014) or mindfulness (Chiesa, Calati, & Serretti, 2011).
Though the concept is not new, most studies on this 
issue are already relatively outdated (Allen, Goldstein, & 
Seaton, 1997; Goldman, 1990). Though some recent stu-
dies (Rupp, Kemmler, Kurz, Hinterhuber, & Fleischhac-
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ker, 2012) contribute promising results, notable contro-
versy arises as to these programs’ real efficiency, structure 
and organization (Bernardin, Maheut-Bosser, & Paille, 
2014). In addition, there is still important vagueness as 
to the real mechanisms implied in these rehabilitation 
programs’ observed improvements, with different studies 
suggesting different mechanisms (Houben, Havermans, 
Nederkoorn, & Jansen, 2012; Houben & Wiers, 2009). 
We must also mention the critique of both methodologies 
applied and external validity of cognitive rehabilitation 
programs in the field of alcoholism (Houben et al., 2011; 
Houben & Wiers, 2009). Altogether, this suggests that evi-
dence on this issue is far from conclusive, and further re-
search is required. 
A wide range of health professionals manage these pro-
grams, but nurses deserve special attention because they 
assume a key role in both detecting and treating alcohol 
dependency. Patient care by nurses combines psychosocial 
interventions, where mental health nurses assume leader-
ship, given their more direct and frequent contact with 
patients (Ryan & Rothwell, 2010). When providing orien-
tation, the nurse takes advantage of the therapeutic rela-
tionship to boost the patient’s motivation and interest in 
rehabilitation therapy.
The purpose of this pilot study was to evaluate the imple-
mentation of rehabilitation therapy within the framework 
of nursing, in alcohol-dependent patients with associated 
cognitive deterioration, and to evaluate the therapy’s viabi-
lity and effectiveness. 
Resources and methods
Pilot study to evaluate the implementation, acceptabili-
ty and preliminary efficiency of a cognitive rehabilitation 
program for patients with alcohol dependence and mild 
NCD. Longitudinal prospective design without control 
group. The study was comprised of a total of 24 alcohol-de-
pendent patients seeking treatment through outpatient 
visits to the Addictive Behaviours Unit (see inclusion crite-
ria) upon agreeing to participate and signing the informed 
consent.
Criteria for participation in the study was as follows. In-
clusion criteria: outpatient services patient, alcohol use di-
sorder (DSM-5) with a minimum of 6 months of abstinence 
beforehand, significant NCD: M@T below 43 and MMSE 
below 28. Exclusion criteria: Serious NCD or any other 
condition (per clinical diagnosis) that prevents correctly 
participating in, or assimilating, the cognitive therapy. 
During 6 months, the Unit nurse led a total of 24, 1-hour 
weekly sessions. The group was comprised of 8-9 patients 
who always held group sessions with the participation of 
all of its members in each. Mental stimulation resources 
and exercises were used to improve cognitive, functional 
and social performance. Written language (prints) and 
spoken language (recall of participants’ names, previous 
tasks, etc.) were alternated. The tasks were completed in 
a classroom specifically adapted for group work, and the 
patients occupied the same place to facilitate name reten-
tion. The contents of the resources used were adapted to 
the patients to the extent possible, regardless of their so-
ciocultural level.
The areas object of the intervention were: 
1. Attention: practiced through visuospatial recognition 
exercises, word searches and differences between pictu-
res.
2. Memory: different memory types were addressed:
a. Semantic memory: implying conceptual information, 
referring to aspects related to the meaning of the in-
formation, addressed in the group through exercises 
involving general knowledge without the recall of spe-
cific events, such as holidays and celebrations.
b. Episodic memory: worked on using information that 
allows for assigning dates and spatially locating infor-
mation in relation to the patients themselves and to 
other events, specifying where and when a given infor-
mation was presented in regard to one’s personal bio-
graphy. This was done by asking questions about each 
patient’s life events, such as: “What did you do yester-
day?” “What have you eaten for breakfast?” “What co-
lour was the shirt you wore yesterday?”
c. Autobiographical memory: the recall of first-hand 
events experienced by each patient was addressed 
through the recall of specific episodes from their lives, 
based on personal and family photographs or objects. 
d. Immediate memory: the recall and/or recognition of 
information received was addressed based on repea-
ting word lists and describing previously presented 
images. 
3. Language: 
a. Automatic language: based on automatic verbal pro-
duction tasks through exercises to recall the months 
of the year, numerical series, and popular sayings or 
proverbs in which the beginning of the saying was pre-
sented, and the patient had to complete the sentence 
and then try to explain its meaning. 
b. Recall: to evaluate and work on aspects related with 
verbal fluency in which the person named the ele-
ments comprising a category (colours, animals, pieces 
of clothing, cities).
c. Spontaneous language: through exercises to describe 
images, prints, situations and occurrences. 
d. Denomination: addressing the content of terms and 
words based on exercises that entailed naming objects 
and the components of objects. 
4. Reading and writing: reading and writing exercises were 
completed based on reading newspaper articles, books 
and short texts.
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5. Executive functions: practiced through exercises to de-
tect similarities and differences, logical series and nume-
rical processing exercises. Though the targets were at-
tention and memory, other fields, such as language and 
executive functions, were alternated as well to maintain 
adherence and retention during the one-hour session.
Three evaluations were completed: at baseline, at the 
end of the sessions (6 months) and 12 months later. The 
initial evaluation gathered sociodemographic data, medi-
cal and psychiatric background and the level of cognitive 
deterioration using the MMSE (Mini-Mental State Exami-
nation) and the M@T (Memory Alteration) scales. The two 
latter ones were also evaluated at 6 and 12 months, as well 
as the patients’ attendance in the therapy sessions and sa-
tisfaction (Annex 1).
Instruments
No specific validation exists for screening cognitive 
deterioration in patients with alcohol use disorder. Most 
published studies, as well as in clinical practice, use those 
tests that are most widely applied in other fields (such as 
dementias). In our case, we used the MMSE and the M@T. 
MMSE: The Mini-Mental State Examination is a test for 
screening dementias, also used for follow-up of their pro-
gress. It is most commonly used to detect and evaluate the 
progress of a Cognitive Disorder associated with neurode-
generative diseases, like Alzheimer (Crum, Anthony, Basse-
tt & Folstein, 1993). It includes five sections: orientation, 
attention, concentration and calculation, memory and lan-
guage. The administration of this simple, structured scale 
requires no more than 5-10 minutes. The maximum, total 
score is 30 points. A score of < 23 points in a geriatric pa-
tient or of < 27 points in the general population is conside-
red cognitive deterioration (Crum et al., 1993).
M@T SCALE: The Memory Alteration Test (M@T) is 
a cognitive screening test with high sensitivity and speci-
ficity for mild cognitive deterioration similar to amnesia, 
and for mild Alzheimer disease, among the general popu-
lation. It is short, easy to administer and score. It evaluates 
several memory subtypes through five sections: immediate 
memory, temporal orientation memory, semantic remote 
memory, free recall memory, and recall memory with cues. 
Administration varies between 5-10 minutes for both heal-
thy patients and those with mild cognitive deterioration. 
Correct answers are summed (1 point). A global score over 
the 50 maximum possible points of the test is recommen-
ded. A score of < 43 points represents significant cognitive 
deterioration (Rami, Molinuevo, Sanchez-Valle, Bosch, & 
Villar, 2007).
Data analysis
Microsoft Office Excel sheets were used to gather and 
analyse the data. SPSS (V.19) was used for statistical analysis. 
Given the sample size and non-normal data, the Friedman 
test was used as a non-parametric method for repeated me-
asures to evaluate the global significance of the study for 
both scales. Post-hoc analysis was completed with the Wil-
coxon signed-rank test, comparing the baseline results with 
the results upon completing the therapy and with those 6 
months later. A 95% confidence interval was used for data 
analysis for p < .05 to contrast the proposed hypothesis.
Results
Table 1 displays sociodemographic data and the medical 
and psychiatric background of patients who attended thera-
py. A total of 24 patients participated, 58.3% were male and 
41.7% were female. The average age was 62 years (minimum 
41, maximum 83). Of these, 4.2% were single, 54.2% were 
married, 33.3% were divorced and 8.3% were widowed. As 
regards educational level, 54.2% had completed elemen-
tary schooling, and the remaining patients had completed 
secondary or upper education. As to employment, 45.8% 
were retired, 4.2% were currently unemployed but had 
worked previously, 33.3% had no paid job at the time, and 
16.6% were currently employed. As regards socioeconomic 
level, 33.3% of the patients currently or previously expe-
rienced difficulties. As to household composition at the 
time of becoming a member of the therapy group, 29.2% 
of the patients lived alone, while the remaining lived with 
the family, mainly with a partner or children. 
Patient health was assessed as to the presence or absen-
ce of cardiovascular risk factors (CRF), noteworthy neuro-
logical diseases and associated psychiatric diagnoses, inde-
pendent of alcohol dependence. As to cardiovascular risk 
factors, 58.3% of the patients were smokers, and approxi-
mately one third of the sample showed dyslipidaemia. A 
lower percentage of patients had diabetes mellitus or obe-
sity. No patients had primary neurological disorders. As 
to a history of neurological diseases, 20.9% of the sample 
showed some type of diagnosis; among these, two patients 
had a diagnosed cerebrovascular disease, one epilepsy and 
another Huntington’s disease. A dual pathology diagnosis 
was common; 66.7% of the patients had a mental disorder, 
depression being predominant (33.3%), followed by per-
sonality disorder (16.75%), anxiety disorder (12.5%) and 
bipolar disorder (4.2%).
Table 2 displays the results of the MMSE and M@T 
scales over the course of the study. The global analysis of 
the Friedman test found statistically significant differen-
ces between the successive values of the MMSE (X2(2) = 
22.86; p < .001) and the M@T (X2(2) = 36.02; p < .001). 
The post-hoc analysis was completed with the Wilcoxon 
signed-rank test and the Bonferroni correction, which es-
tablished statistical significance at p < .0125. As regards the 
MMSE scale, the medians and interquartile range for the 
values at baseline, upon completion of the treatment, and 
6 months later were 27 (from 25.25 to 28), 29 (from 28 to 
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Table 1. Sociodemographic data of the sample.
Variable Characteristics of the sample 
Mean (SD) or percentage
Age 61,83 (12.25)
Gender (% female) 41.7%
Marital status
 unmarried
 married
 divorced
 widowed
4.2%
54.%
33.3%
8.3%
Level of education
 primary
 secondary
 occupational training
 3-year university degree
 5-year university degree
54.2%
16.7%
16.7%
8.3%
4.2%
Employment status
 unemployed
 unskilled worker
 skilled worker
 unemployment benefits
 pensioner
 
33.3%
8.3%
8.3%
4.2%
45.8%
Socioeconomic level
 lower class
 middle class
33.3%
66.7%
Household composition
 alone
 spouse
 spouse and children
 children
 parents/siblings
29,2%
41,7%
12,5%
12,5%
4,2%
Comorbid psychiatric disorder 66,7%
Pharmacological treatments
 antipsychotics
 benzodiazepines
 antidepressants
 interdictor
20.8%
12.5%
33.3%
37.5%
Smokers 41.7%
Note. SD = Standard Deviation.
Table 2. Values of the MMSE and M@T at baseline, end of 
treatment and 6 months.
Scale
Baseline
Mean (SD)
End 
Mean (SD)
At 6 months 
Mean (SD)
MMSE 26.58 (2,7) 28.92 (1,4) 27.71 (2,8)
T@M 39.79 (6,4) 46.00 (4,8) 42.21 (7,5)
Note. SD = Standard Deviation. MMSE = Mini-Mental State Examination. M@T = 
Memory Alteration Test.
30) and 28 (from 27 to 30). Significant differences were 
found between the values at baseline and at the end of the 
treatment (z = -4.05; p < .001), while no significant diffe-
rences were found between the values at baseline and at 6 
months after the end of the treatment (z = -2.392; p = .017). 
As regards the M@T scale, the medians and interquartile 
range for the values at baseline, upon completion of the 
treatment, and 6 months later were 40 (from 37 to 45.5), 
47.5 (from 44 to 49) and 44.5 (from 40 to 48). Significant 
differences were found between the values at baseline and 
at the end of the treatment (z = -4.3; p < .001), as well as 
between the values at baseline and at 6 months after the 
end of the treatment (z = -2.6; p = .009).
Missed attendance was anecdotal: 7%. As regards satis-
faction with the therapy, 3% of the patients was satisfied 
and 97% was very satisfied. During follow-up of the study, 
all of the patients remained abstinent, according to the 
usual urine tests and self-reports completed by patients 
and their family members. 
Discussion
The results of this pilot study suggest how cognitive re-
habilitation therapy, when integrated in the treatment for 
alcohol dependency, could facilitate improved cognitive 
functioning in patients with cognitive deterioration asso-
ciated with alcohol use, in accordance with general cogni-
tive screening tests, like the M@T and the MMSE. The data 
collected over the course of the study suggest that the im-
provement observed upon completion of the study tends 
to be lost at 6 months after the end of the intervention.
It is important to highlight the pilot nature of this study, 
implying the absence of a control group and a small sam-
ple size. This means that the observed cognitive improve-
ments cannot be definitely attributed to the direct effects 
of the therapy. Any type of intervention that facilitates 
social interaction and fosters some cognitive effort could 
have caused improvements in the patients’ cognition or 
mood state, and this could have acted as a confounding 
variable in our analysis. Furthermore, other secondary 
effects, such as a greater presence of or closer supervision 
by the health professionals in relation to the patients, also 
exist. We must also mention that part of the improved pro-
gress observed could be spontaneous, as it is known that 
some cognitive functions improve spontaneously during 
prolonged periods of abstinence. Even so, we consider that 
the fact that patients remained abstinent 6 months before 
and 6 months after the intervention increases the validity 
of the results. Again, given that this is a pilot study without 
a control group, conclusions cannot be drawn as to whe-
ther the observed improvement contributed toward main-
taining abstinence in subsequent months, a fact confirmed 
by other studies (Rupp et al., 2012). Special mention must 
also be made of the use of instruments like the M@T and 
the MMSE, lacking high specificity and usually used as 
screening methods. Nevertheless, these are widely-used 
instruments validated in many contexts and have been 
shown to partially correlate with broader neuropsycholo-
gical batteries (Rami et al., 2009), wherefore they may be 
considered an acceptable approximation of the cognitive 
state of the study’s participants. 
The fact that both levels of attendance and patient sa-
tisfaction were high suggests that the intervention was wi-
dely accepted. The fact that these patients’ nurse led the 
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intervention could be an important variable in explaining 
this high satisfaction and acceptance. This could have sig-
nificant implications as regards future research, suggesting 
that the implementation of the therapy by the patients’ 
attending health professionals could improve its imple-
mentation and, therefore, facilitate or contribute toward 
achieving higher efficiency. 
The study has major limitations derived of the criteria 
used for selecting patients to participate in the therapy. Ba-
sed on the demand of patients and their family members 
as well as of professionals, with regards to the detection 
of cognitive impairment symptoms, the patient sample was 
quite heterogeneous, mostly in health-related issues. In this 
sense, the presence of patients with and without neurologi-
cal disorders, as well as others with a dual diagnosis, could 
justify the scarce homogeneity of results in the MMSE and 
M@T scales. All of this hinders drawing conclusions on 
causality as regards the possible aetiology of the cognitive 
deterioration. Though it is true that all patients met crite-
ria of alcohol dependency, it is quite likely that, in many 
cases, the observed deterioration had a mixed source. Ano-
ther significant limitation is general and not study-specific: 
the absence of neurocognitive evaluation tests validated 
specifically in alcohol-dependent populations and which, 
furthermore, have proven their sensitivity to changes in 
the long term. Many authors have emphasized this, and 
it should be a focus of future research. Finally, given the 
pragmatic and exploratory study design, the effect of lear-
ning could not be controlled in patients in which it could 
have resulted of completing the same test several times 
over 12 months. 
Conclusions
This pilot study shows how cognitive rehabilitation the-
rapy in patients with cognitive deterioration and alcohol 
use disorder is viable and widely accepted by the patients. 
The study’s important methodological limitations hinder 
obtaining valid conclusions about its efficacy. Nevertheless, 
preliminary exploratory data suggest that the intervention 
could contribute toward improving this population’s cog-
nitive functioning. The promotion of research in this field 
is of critical importance, given its potential positive impact 
on a highly relevant health problem. To this end, it would 
be convenient to first validate neurocognitive screening 
and evaluation tests in patients with alcohol use disorder 
that are sensitive to changes over time; then, to carry out 
prospective longitudinal studies with comparison groups 
for different rehabilitation approaches. 
Conflict of interests
The authors declare the inexistence of conflicts of inte-
rest with regard to this study. 
References
Alfonso, J. P., Caracuel, A., Delgado-Pastor, L. C., & Ver-
dejo-García, A. (2011). Combined Goal Management 
Training and Mindfulness meditation improve executi-
ve functions and decision-making performance in absti-
nent polysubstance abusers. Drug and Alcohol Dependence, 
117, 78–81. doi:10.1016/j.drugalcdep.2010.12.025
Allen, D. N., Goldstein, G., & Seaton, B. E. (1997). Cogni-
tive rehabilitation of chronic alcohol abusers. Neuropsy-
chology Review, 7, 21–39. 
American Psychiatric Association. (2013). Diagnostic and sta-
tistical manual of mental disorders (5th ed). Washington, DC. 
Bates, M., & Buckam, J. (2013.). Integrating body and bra-
in systems in addiction neuroscience. In P. Miller (Ed.), 
Encyclopedia of Addictive Behaviors. Elsevier.
Bates, M. E., Bowden, S. C., & Barry, D. (2002). Neurocog-
nitive impairment associated with alcohol use disorders: 
implications for treatment. Experimental and Clinical Psy-
chopharmacology, 10, 193–212. 
Bates, M. E., Buckman, J. F., & Nguyen, T. T. (2013). A role 
for cognitive rehabilitation in increasing the effective-
ness of treatment for alcohol use disorders. Neuropsycho-
logy Review, 23, 27–47. doi:10.1007/s11065-013-9228-3
Bernardin, F., Maheut-Bosser, A., & Paille, F. (2014). Cog-
nitive impairments in alcohol-dependent subjects. Fron-
tiers in Psychiatry, 5, 78. doi:10.3389/fpsyt.2014.00078
Bickel, W. K., Yi, R., Landes, R. D., Hill, P. F., & Baxter, 
C. (2011). Remember the future: working memory 
training decreases delay discounting among stimulant 
addicts. Biological Psychiatry, 69, 260–265. doi:10.1016/j.
biopsych.2010.08.017
Brown, R. A., Abrantes, A. M., Minami, H., Read, J. P., Mar-
cus, B. H., Jakicic, J. M., … Stuart, G. L. (2014). A pre-
liminary, randomized trial of aerobic exercise for alco-
hol dependence. Journal of Substance Abuse Treatment, 47, 
1–9. doi:10.1016/j.jsat.2014.02.004
Chiesa, A., Calati, R., & Serretti, A. (2011). Does mindful-
ness training improve cognitive abilities? A systematic 
review of neuropsychological findings. Clinical Psychology 
Review, 31, 449–464. doi:10.1016/j.cpr.2010.11.003
Crum, R. M., Anthony, J. C., Bassett, S. S., & Folstein, M. 
F. (1993). Population-based norms for the Mini-Mental 
State Examination by age and educational level. JAMA, 
269, 2386–2391. 
Glass, J. M., Buu, A., Adams, K. M., Nigg, J. T., Puttler, L. 
I., Jester, J. M., & Zucker, R. A. (2009). Effects of alco-
holism severity and smoking on executive neurocogni-
tive function. Addiction, 104, 38–48. doi:10.1111/j.1360-
0443.2008.02415.x
Goldman, M. S. (1990). Experience-dependent neuropsy-
chological recovery and the treatment of chronic alco-
holism. Neuropsychology Review, 1, 75–101. 
Gongvatana, A., Morgan, E. E., Iudicello, J. E., Letendre, S. 
L., Grant, I., & Woods, S. P. (2014). A history of alcohol 
ADICCIONES, 2018 · VOL. 30 NO. 2
99
Cindy Frías-Torres, José Moreno-España, Lluisa Ortega, Pablo Barrio, Antoni Gual, Lídia Teixidor
dependence augments HIV-associated neurocognitive 
deficits in persons aged 60 and older. Journal of Neurovi-
rology, 20, 505–513. doi:10.1007/s13365-014-0277-z
Houben, K., Havermans, R. C., Nederkoorn, C., & Jansen, 
A. (2012). Beer à no-go: learning to stop responding to 
alcohol cues reduces alcohol intake via reduced affec-
tive associations rather than increased response inhi-
bition. Addiction, 107, 1280–1287. doi:10.1111/j.1360-
0443.2012.03827.x
Houben, K., & Wiers, R. W. (2009). Response inhibition 
moderates the relationship between implicit associa-
tions and drinking behavior. Alcoholism, Clinical and 
Experimental Research, 33, 626–633. doi:10.1111/j.1530-
0277.2008.00877.x
Houben, K., Wiers, R. W., & Jansen, A. (2011). Getting a 
grip on drinking behavior: training working memory to 
reduce alcohol abuse. Psychological Science, 22, 968–975. 
doi:10.1177/0956797611412392
Huebner, R. B., & Kantor, L. W. (2010). Advances in alco-
holism treatment. Alcohol Research and Health, 33, 295-
299.
Lawrence, A. J., Luty, J., Bogdan, N. A., Sahakian, B. J., & 
Clark, L. (2009). Problem gamblers share deficits in im-
pulsive decision-making with alcohol-dependent indi-
viduals. Addiction, 104, 1006–1015. doi:10.1111/j.1360-
0443.2009.02533.x
Levine, B., Schweizer, T. A., O’Connor, C., Turner, G., Gi-
llingham, S., Stuss, D. T., … Robertson, I. H. (2011). 
Rehabilitation of executive functioning in patients with 
frontal lobe brain damage with goal management trai-
ning. Frontiers in Human Neuroscience, 5, 9. doi:10.3389/
fnhum.2011.00009
Miller, P., Plant, M. L., Plant, M. A., Ozenturk, T., Do-
yle, D., Fong, J., & Mylchreest, K. (2008). Gender, al-
cohol, drugs, and health: A comparison of the Isle of 
Man and the UK. Journal of Substance Use, 13, 389–403. 
doi:10.1080/14659890802211762
Pedrero-Perez, E. J., Rojo-Mota, G., Ruiz-Sanchez de Leon, 
J. M., Llanero-Luque, M., & Puerta-Garcia, C. (2011). 
Cognitive remediation in addictions treatment. Revista 
de Neurologia, 52, 163–172. 
Rami, L., Bosch, B., Valls-Pedret, C., Caprile, C., Sán-
chez-Valle Díaz, R., & Molinuevo, J. L. (2009). Discrimi-
natory validity and association of the mini-mental test 
(MMSE) and the memory alteration test (M@T) with 
a neuropsychological battery in patients with amnestic 
mild cognitive impairment and Alzheimer’s disease. Re-
vista de Neurologia, 49, 169-174. 
Rami, L., Molinuevo, J. L., Sanchez-Valle, R., Bosch, B., & 
Villar, A. (2007). Screening for amnestic mild cogniti-
ve impairment and early Alzheimer’s disease with M@T 
(Memory Alteration Test) in the primary care popula-
tion. International Journal of Geriatric Psychiatry, 22, 294–
304. doi:10.1002/gps.1672
Rojo-Mota, G., Pedrero Pérez, E. J., Ruiz Sánchez de León, 
J. M., Llanero Luque, M., Olivar Arroyo, Á., & Puerta 
García, C. (2009). Terapia Ocupacional en la rehabili-
tación de la disfunción ejecutiva en adictos a sustancias. 
Trastornos Adictivos, 11, 96–105. doi:10.1016/S1575-
0973(09)72057-4
Rosón Hernández, B. (2008). Consumo de riesgo y perju-
dicial de aclohol. Prevalencia y metodos de deteccion en 
la práctica clínica. Galicia Clínica, 69, 29–44.
Rupp, C. I., Fleischhacker, W. W., Drexler, A., Hausmann, 
A., Hinterhuber, H., & Kurz, M. (2006). Executive func-
tion and memory in relation to olfactory deficits in 
alcohol-dependent patients. Alcoholism, Clinical and Ex-
perimental Research, 30, 1355–1362. doi:10.1111/j.1530-
0277.2006.00162.x
Rupp, C. I., Kemmler, G., Kurz, M., Hinterhuber, H., & 
Fleischhacker, W. W. (2012). Cognitive remediation the-
rapy during treatment for alcohol dependence. Journal 
of Studies on Alcohol and Drugs, 73, 625–634. 
Ryan, T., & Rothwell, V. (2010). Residential alcohol detoxi-
fication: new role for mental health nurses. British Journal 
of Nursing, 6, 280–284. doi:10.12968/bjon.1997.6.5.280
Schuckit, M. A. (2009). Alcohol-use disorders. Lancet, 373, 
492–501. doi:10.1016/S0140-6736(09)60009-X
Soler-González, C., Balcells-Oliveró, M., & Gual-Solé, A. 
(2014). Alcohol related brain damage. State of the art 
and a call for action. Adicciones, 26, 199–207. 
Surkan, P. J., Fielding-Miller, R., & Melchior, M. (2012). 
Parental relationship satisfaction in French young 
adults associated with alcohol abuse and dependen-
ce. Addictive Behaviors, 33, 313–317. doi:10.1016/j.add-
beh.2011.10.008
Varela-Rey, M., Woodhoo, A., Martinez-Chantar, M.-L., 
Mato, J. M., & Lu, S. C. (2013). Alcohol, DNA methyla-
tion, and cancer. Alcohol Research: Current Reviews, 35, 
25–35. 
Wiers, R. W., Eberl, C., Rinck, M., Becker, E. S., & Lin-
denmeyer, J. (2011). Retraining automatic action ten-
dencies changes alcoholic patients’ approach bias for 
alcohol and improves treatment outcome. Psychological 
Science, 22), 490–497. doi:10.1177/0956797611400615
Yeh, P.-H., Gazdzinski, S., Durazzo, T. C., Sjöstrand, K., & 
Meyerhoff, D. J. (2007). Hierarchical linear modeling 
(HLM) of longitudinal brain structural and cogniti-
ve changes in alcohol-dependent individuals during 
sobriety. Drug and Alcohol Dependence, 91, 195–204. 
doi:10.1016/j.drugalcdep.2007.05.027

